Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1032 entries
Sorted by: Best Match Show Resources per page
Neurodegenerative disease: EPHA4 inhibition rescues neurodegeneration in ALS.

Nature reviews. Drug discovery

Faruqi M.
PMID: 23023674
Nat Rev Drug Discov. 2012 Oct;11(10):747. doi: 10.1038/nrd3853.

No abstract available.

Cite
Faruqi M. Neurodegenerative disease: EPHA4 inhibition rescues neurodegeneration in ALS. Nat Rev Drug Discov. 2012;11(10):747doi: 10.1038/nrd3853.
Faruqi, M. (2012). Neurodegenerative disease: EPHA4 inhibition rescues neurodegeneration in ALS. Nature reviews. Drug discovery, 11(10), 747. https://doi.org/10.1038/nrd3853
Faruqi, Mariam. "Neurodegenerative disease: EPHA4 inhibition rescues neurodegeneration in ALS." Nature reviews. Drug discovery vol. 11,10 (2012): 747. doi: https://doi.org/10.1038/nrd3853
Faruqi M. Neurodegenerative disease: EPHA4 inhibition rescues neurodegeneration in ALS. Nat Rev Drug Discov. 2012 Oct;11(10):747. doi: 10.1038/nrd3853. PMID: 23023674.
Copy Download .nbib Format: NLM
Vaccines: Self-amplifying RNA in lipid nanoparticles: a next-generation vaccine?.

Nature reviews. Drug discovery

Flemming A.
PMID: 23023675
Nat Rev Drug Discov. 2012 Oct;11(10):748-9. doi: 10.1038/nrd3854.

No abstract available.

Cite
Flemming A. Vaccines: Self-amplifying RNA in lipid nanoparticles: a next-generation vaccine?. Nat Rev Drug Discov. 2012;11(10):748-9doi: 10.1038/nrd3854.
Flemming, A. (2012). Vaccines: Self-amplifying RNA in lipid nanoparticles: a next-generation vaccine?. Nature reviews. Drug discovery, 11(10), 748-9. https://doi.org/10.1038/nrd3854
Flemming, Alexandra. "Vaccines: Self-amplifying RNA in lipid nanoparticles: a next-generation vaccine?." Nature reviews. Drug discovery vol. 11,10 (2012): 748-9. doi: https://doi.org/10.1038/nrd3854
Flemming A. Vaccines: Self-amplifying RNA in lipid nanoparticles: a next-generation vaccine?. Nat Rev Drug Discov. 2012 Oct;11(10):748-9. doi: 10.1038/nrd3854. PMID: 23023675.
Copy Download .nbib Format: NLM
Obesity and diabetes: lipid boosts muscle and shrinks fat.

Nature reviews. Drug discovery

Burridge S.
PMID: 21804591
Nat Rev Drug Discov. 2011 Aug 01;10(8):576. doi: 10.1038/nrd3522.

No abstract available.

Cite
Burridge S. Obesity and diabetes: lipid boosts muscle and shrinks fat. Nat Rev Drug Discov. 2011;10(8):576doi: 10.1038/nrd3522.
Burridge, S. (2011). Obesity and diabetes: lipid boosts muscle and shrinks fat. Nature reviews. Drug discovery, 10(8), 576. https://doi.org/10.1038/nrd3522
Burridge, Samia. "Obesity and diabetes: lipid boosts muscle and shrinks fat." Nature reviews. Drug discovery vol. 10,8 (2011): 576. doi: https://doi.org/10.1038/nrd3522
Burridge S. Obesity and diabetes: lipid boosts muscle and shrinks fat. Nat Rev Drug Discov. 2011 Aug 01;10(8):576. doi: 10.1038/nrd3522. PMID: 21804591.
Copy Download .nbib Format: NLM
FDA rejects first-in-class osteoporosis drug.

Nature reviews. Drug discovery

Mullard A.
PMID: 28860584
Nat Rev Drug Discov. 2017 Sep 01;16(9):593. doi: 10.1038/nrd.2017.176.

No abstract available.

Cite
Mullard A. FDA rejects first-in-class osteoporosis drug. Nat Rev Drug Discov. 2017;16(9):593doi: 10.1038/nrd.2017.176.
Mullard, A. (2017). FDA rejects first-in-class osteoporosis drug. Nature reviews. Drug discovery, 16(9), 593. https://doi.org/10.1038/nrd.2017.176
Mullard, Asher. "FDA rejects first-in-class osteoporosis drug." Nature reviews. Drug discovery vol. 16,9 (2017): 593. doi: https://doi.org/10.1038/nrd.2017.176
Mullard A. FDA rejects first-in-class osteoporosis drug. Nat Rev Drug Discov. 2017 Sep 01;16(9):593. doi: 10.1038/nrd.2017.176. PMID: 28860584.
Copy Download .nbib Format: NLM
Diabetes drug shows promise in Parkinson disease.

Nature reviews. Drug discovery

Mullard A.
PMID: 28860589
Nat Rev Drug Discov. 2017 Sep 01;16(9):593. doi: 10.1038/nrd.2017.175.

No abstract available.

Cite
Mullard A. Diabetes drug shows promise in Parkinson disease. Nat Rev Drug Discov. 2017;16(9):593doi: 10.1038/nrd.2017.175.
Mullard, A. (2017). Diabetes drug shows promise in Parkinson disease. Nature reviews. Drug discovery, 16(9), 593. https://doi.org/10.1038/nrd.2017.175
Mullard, Asher. "Diabetes drug shows promise in Parkinson disease." Nature reviews. Drug discovery vol. 16,9 (2017): 593. doi: https://doi.org/10.1038/nrd.2017.175
Mullard A. Diabetes drug shows promise in Parkinson disease. Nat Rev Drug Discov. 2017 Sep 01;16(9):593. doi: 10.1038/nrd.2017.175. PMID: 28860589.
Copy Download .nbib Format: NLM
TransCelerate makes progress.

Nature reviews. Drug discovery

Mullard A.
PMID: 28356586
Nat Rev Drug Discov. 2017 Mar 30;16(4):229. doi: 10.1038/nrd.2017.63.

No abstract available.

Cite
Mullard A. TransCelerate makes progress. Nat Rev Drug Discov. 2017;16(4):229doi: 10.1038/nrd.2017.63.
Mullard, A. (2017). TransCelerate makes progress. Nature reviews. Drug discovery, 16(4), 229. https://doi.org/10.1038/nrd.2017.63
Mullard, Asher. "TransCelerate makes progress." Nature reviews. Drug discovery vol. 16,4 (2017): 229. doi: https://doi.org/10.1038/nrd.2017.63
Mullard A. TransCelerate makes progress. Nat Rev Drug Discov. 2017 Mar 30;16(4):229. doi: 10.1038/nrd.2017.63. PMID: 28356586.
Copy Download .nbib Format: NLM
Asthma: Alternative route to airway relaxation.

Nature reviews. Drug discovery

Crunkhorn S.
PMID: 29545549
Nat Rev Drug Discov. 2018 Apr;17(4):241. doi: 10.1038/nrd.2018.37. Epub 2018 Mar 16.

No abstract available.

Cite
Crunkhorn S. Asthma: Alternative route to airway relaxation. Nat Rev Drug Discov. 2018;17(4):241doi: 10.1038/nrd.2018.37.
Crunkhorn, S. (2018). Asthma: Alternative route to airway relaxation. Nature reviews. Drug discovery, 17(4), 241. https://doi.org/10.1038/nrd.2018.37
Crunkhorn, Sarah. "Asthma: Alternative route to airway relaxation." Nature reviews. Drug discovery vol. 17,4 (2018): 241. doi: https://doi.org/10.1038/nrd.2018.37
Crunkhorn S. Asthma: Alternative route to airway relaxation. Nat Rev Drug Discov. 2018 Apr;17(4):241. doi: 10.1038/nrd.2018.37. Epub 2018 Mar 16. PMID: 29545549.
Copy Download .nbib Format: NLM
The multiple sclerosis market.

Nature reviews. Drug discovery

Westad A, Venugopal A, Snyder E.
PMID: 28642610
Nat Rev Drug Discov. 2017 Oct;16(10):675-676. doi: 10.1038/nrd.2017.107. Epub 2017 Jun 23.

No abstract available.

Cite
Westad A, Venugopal A, Snyder E. The multiple sclerosis market. Nat Rev Drug Discov. 2017;16(10):675-676doi: 10.1038/nrd.2017.107.
Westad, A., Venugopal, A., & Snyder, E. (2017). The multiple sclerosis market. Nature reviews. Drug discovery, 16(10), 675-676. https://doi.org/10.1038/nrd.2017.107
Westad, Anders, et al. "The multiple sclerosis market." Nature reviews. Drug discovery vol. 16,10 (2017): 675-676. doi: https://doi.org/10.1038/nrd.2017.107
Westad A, Venugopal A, Snyder E. The multiple sclerosis market. Nat Rev Drug Discov. 2017 Oct;16(10):675-676. doi: 10.1038/nrd.2017.107. Epub 2017 Jun 23. PMID: 28642610.
Copy Download .nbib Format: NLM
UK academic drug discovery.

Nature reviews. Drug discovery

Tralau-Stewart C, Low CM, Marlin N.
PMID: 24378794
Nat Rev Drug Discov. 2014 Jan;13(1):15-6. doi: 10.1038/nrd4200.

No abstract available.

Cite
Tralau-Stewart C, Low CM, Marlin N. UK academic drug discovery. Nat Rev Drug Discov. 2014;13(1):15-6doi: 10.1038/nrd4200.
Tralau-Stewart, C., Low, C. M., & Marlin, N. (2014). UK academic drug discovery. Nature reviews. Drug discovery, 13(1), 15-6. https://doi.org/10.1038/nrd4200
Tralau-Stewart, Cathy, et al. "UK academic drug discovery." Nature reviews. Drug discovery vol. 13,1 (2014): 15-6. doi: https://doi.org/10.1038/nrd4200
Tralau-Stewart C, Low CM, Marlin N. UK academic drug discovery. Nat Rev Drug Discov. 2014 Jan;13(1):15-6. doi: 10.1038/nrd4200. PMID: 24378794.
Copy Download .nbib Format: NLM
Cancer immunotherapy: When viruses attack.

Nature reviews. Drug discovery

Dart A.
PMID: 29081525
Nat Rev Drug Discov. 2017 Oct 30;16(11):752-753. doi: 10.1038/nrd.2017.220.

No abstract available.

Cite
Dart A. Cancer immunotherapy: When viruses attack. Nat Rev Drug Discov. 2017;16(11):752-753doi: 10.1038/nrd.2017.220.
Dart, A. (2017). Cancer immunotherapy: When viruses attack. Nature reviews. Drug discovery, 16(11), 752-753. https://doi.org/10.1038/nrd.2017.220
Dart, Anna. "Cancer immunotherapy: When viruses attack." Nature reviews. Drug discovery vol. 16,11 (2017): 752-753. doi: https://doi.org/10.1038/nrd.2017.220
Dart A. Cancer immunotherapy: When viruses attack. Nat Rev Drug Discov. 2017 Oct 30;16(11):752-753. doi: 10.1038/nrd.2017.220. PMID: 29081525.
Copy Download .nbib Format: NLM
How much do clinical trials cost?.

Nature reviews. Drug discovery

Martin L, Hutchens M, Hawkins C, Radnov A.
PMID: 28529317
Nat Rev Drug Discov. 2017 Jun;16(6):381-382. doi: 10.1038/nrd.2017.70. Epub 2017 May 19.

No abstract available.

Cite
Martin L, Hutchens M, Hawkins C, et al. How much do clinical trials cost?. Nat Rev Drug Discov. 2017;16(6):381-382doi: 10.1038/nrd.2017.70.
Martin, L., Hutchens, M., Hawkins, C., & Radnov, A. (2017). How much do clinical trials cost?. Nature reviews. Drug discovery, 16(6), 381-382. https://doi.org/10.1038/nrd.2017.70
Martin, Linda, et al. "How much do clinical trials cost?." Nature reviews. Drug discovery vol. 16,6 (2017): 381-382. doi: https://doi.org/10.1038/nrd.2017.70
Martin L, Hutchens M, Hawkins C, Radnov A. How much do clinical trials cost?. Nat Rev Drug Discov. 2017 Jun;16(6):381-382. doi: 10.1038/nrd.2017.70. Epub 2017 May 19. PMID: 28529317.
Copy Download .nbib Format: NLM
CNS injury: Promoting neural repair.

Nature reviews. Drug discovery

Crunkhorn S.
PMID: 28935917
Nat Rev Drug Discov. 2017 Oct;16(10):680. doi: 10.1038/nrd.2017.183. Epub 2017 Sep 22.

No abstract available.

Cite
Crunkhorn S. CNS injury: Promoting neural repair. Nat Rev Drug Discov. 2017;16(10):680doi: 10.1038/nrd.2017.183.
Crunkhorn, S. (2017). CNS injury: Promoting neural repair. Nature reviews. Drug discovery, 16(10), 680. https://doi.org/10.1038/nrd.2017.183
Crunkhorn, Sarah. "CNS injury: Promoting neural repair." Nature reviews. Drug discovery vol. 16,10 (2017): 680. doi: https://doi.org/10.1038/nrd.2017.183
Crunkhorn S. CNS injury: Promoting neural repair. Nat Rev Drug Discov. 2017 Oct;16(10):680. doi: 10.1038/nrd.2017.183. Epub 2017 Sep 22. PMID: 28935917.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1032 entries